In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 34 for your search:
Drug:  eflornithine
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: ILEX-DFMO341, N01-CN-25434-01, UCLA-9812049, UF-453-1998, WCCC-CO-98803, NCI-G99-1509, NCT00003814

2.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 5 to 45
Sponsor: NCI
Protocol IDs: NCOG-6G871, BTRC-8625, MDA-DM-88056, NCI-T86-0226D, T86-0226

3.

Phase: Phase III
Type: Treatment
Status: Completed
Age: over 18
Sponsor: NCI
Protocol IDs: BTRC-6G901, NCI-T91-0047O, T91-0047

4.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: NCI
Protocol IDs: MDA-DM-92035, NCI-T92-0114C, T92-0114

5.

Phase: Phase III
Type: Prevention
Status: Completed
Age: 40 to 80
Sponsor: NCI
Protocol IDs: NCI-2009-00880, UCI 97-05, R01CA088078, UCIRVINE-UCI-2002-2261, NCT00118365

6.

Phase: Phase III
Type: Prevention
Status: Completed
Age: 21 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000067928, U01CA077158, WCCC-CO-9737, NCI-P00-0155, NCT00005884

7.

Phase: Phase II, Phase I
Type: Prevention
Status: Closed
Age: Over 18
Sponsor: NCI
Protocol IDs: WCCC-CO-9221, NCI-P97-0096

8.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-8525A, NCI-T85-0043D, T85-0043

9.

Phase: Phase II
Type: Prevention, Screening
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: WCCC-CO-9285, NCI-G97-1213

10.

Phase: Phase II
Type: Prevention
Status: Closed
Age: 30-55 with exceptions
Sponsor: NCI
Protocol IDs: KUMC-HSC-6916-96, NCI-P97-0080

11.

Phase: Phase II
Type: Prevention
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UAB-9509, NCI-P97-0082

12.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: Over 18
Sponsor: NCI, Other
Protocol IDs: CDR0000065763, P30CA046592, CCUM-9555, NCI-P97-0094, NCT00003076

13.

Phase: Phase II
Type: Prevention
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: FCCC-94021, NCI-P97-0095

14.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: ID92-026, P30CA016672, MDA-ID-92026, NCI-P00-0149, CDR0000067921, NCT00006079

15.

Phase: Phase II
Type: Prevention
Status: Closed
Age: 35 to 70
Sponsor: NCI, Other
Protocol IDs: CDR0000068110, UCIRVINE-97-18, UCIRVINE-U01-CA-81886-01, NCI-P00-0164, NCT00006101

16.

Phase: Phase II
Type: Prevention
Status: Completed
Age: 18 to 65
Sponsor: NCI
Protocol IDs: NCI-2013-00844, CDR0000069278, N01-CN95040, NCI-P02-0219, P30CA016672, ID00-109, MDA-ID-00109, NCT00033371

17.

Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: NCI-84-C-179, NCI-T84-0477N, T84-0477

18.

Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: RPMI-PPC-764, NCI-T83-0886D

19.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: NCI
Protocol IDs: MDA-DM-88130, NCI-T88-0236H, T88-0236

20.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MAYO-867202, NCI-T89-0006C, T89-0006

21.

Phase: Phase II
Type: Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-895151, EST-C-0490, MAYO-895151, I89-0001, NCI-P91-0008

22.

Phase: Phase II
Type: Prevention
Status: Closed
Age: 40 to 80
Sponsor: Other
Protocol IDs: UCI-DFMO/COLON, NCI-P92-0007

23.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000353198, UAB-9921, UAB-F990728039, NCT00086736

24.

Phase: Phase II
Type: Prevention
Status: Completed
Age: 21 and over
Sponsor: Other
Protocol IDs: 2001-414, CO00318, NCT00204789

25.

Phase: Phase II
Type: Prevention
Status: Completed
Age: 40 to 80
Sponsor: NCI, Other
Protocol IDs: CDR0000067922, 1997-96, NCI-P00-0150, UCIRVINE-97-05, NCT00005882
1   
New Search